DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Sarah Hill, Dermatology Registrar, Waikato Hospital, 2006.
SAPHO syndrome is characterised by any combination of:
The cause is unknown.
The skin lesions in SAPHO syndrome are characterised on skin biopsy by collections of inflammatory cells, known as neutrophilic pseudoabscesses.
Bony involvement mostly affects the breast bone (sternum), resulting in decreased mobility due to pain, tenderness and swelling. The collar bones (clavicles) are also frequently enlarged on X-ray. Bone biopsy also reveals abscesses, known as sterile osteomyelitis.
SAPHO syndrome is classified along three different spectrums.
Prevalence of CRMO is estimated at 0.04% whilst the other entities are rarer.
SAPHO syndrome is suspected when a patient presents with a pustular skin disease in association with rheumatic pain.
Magnetic resonance imaging (MRI scan) shows inflammation of the bone marrow or joints at characteristic sites such as the collar bone, breast bone, pelvis, heel, and lower jaw.
SAPHO has no specific drug treatment. It can be a chronic condition but eventually self-heals.
A rheumatologist may manage the joint symptoms, often prescribing nonsteroidal anti-inflammatory drugs or sulfonamides such as sulfasalazine.
Other drugs that may be used include:
See the DermNet NZ bookstore
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.